Can oncogene and tumor suppressor genes aid in assessing node-negative mammary tumors? (Englisch)
- Neue Suche nach: Hoefler, H.
- Neue Suche nach: Atkinson, M. J.
- Neue Suche nach: Luz, A.
- Neue Suche nach: Hoefler, H.
- Neue Suche nach: Atkinson, M. J.
- Neue Suche nach: Luz, A.
- Neue Suche nach: Schmitt, M.
- Neue Suche nach: Graeff, H.
- Neue Suche nach: Kindermann, G.
In:
Prospects in diagnosis and treatment of breast cancer
;
3-10
;
1994
-
ISBN:
-
ISSN:
- Aufsatz (Konferenz) / Print
-
Titel:Can oncogene and tumor suppressor genes aid in assessing node-negative mammary tumors?
-
Beteiligte:Hoefler, H. ( Autor:in ) / Atkinson, M. J. ( Autor:in ) / Luz, A. ( Autor:in ) / Schmitt, M. / Graeff, H. / Kindermann, G.
-
Kongress:Joint international symposium, Prospects in diagnosis and treatment of breast cancer ; 1993 ; Munich; Germany
-
Erschienen in:EXCERPTA MEDICA INTERNATIONAL CONGRESS SERIES ; 1050 ; 3-10
-
Verlag:
- Neue Suche nach: Excerpta Medica
-
Erscheinungsort:Amsterdam , New York
-
Erscheinungsdatum:01.01.1994
-
Format / Umfang:8 pages
-
Anmerkungen:p. cm.
-
ISBN:
-
ISSN:
-
Medientyp:Aufsatz (Konferenz)
-
Format:Print
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis Konferenzband
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 3
-
Can oncogene and tumor suppressor genes aid in assessing node-negative mammary tumors?Hoefler, H. / Atkinson, M. J. / Luz, A. et al. | 1994
- 11
-
Functional analysis of tumor suppressor p53Deppert, W. et al. | 1994
- 23
-
Recent advances in studies of gene expression in clinical breast materialAuer, G. / Franzen, B. / Eriksson, E. / Baeckdahi, M. et al. | 1994
- 33
-
Prognostic significance of histological and immunohistological tumor characteristics in node-negative breast cancer patientsDimpfl, T. / Assemi, C. / Genz, T. et al. | 1994
- 39
-
New antibodies for the detection of the Ki-67 proteinKubbutat, M. H. G. / Gerdes, J. / Key, G. et al. | 1994
- 47
-
Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Their relation to clinical factors, DNA parameters and clinical courseAubele, M. / Auer, G. / Juetting, U. / Gais, P. et al. | 1994
- 57
-
Patterns of keratin expression and differentiation of breast cancerNathrath, W. B. J. / Lane, E. B. et al. | 1994
- 63
-
Flow cytometric DNA analysis in primary breast cancer: technical pitfalls and clinical applicationsHarbeck, N. / Yamamoto, N. / Moniwa, N. / Schueren, E. et al. | 1994
- 77
-
Structure and function of matrix metalloproteinases and their significance in breast cancerTschesche, H. / Blaeser, J. / Kleine, T. / Bode, W. et al. | 1994
- 89
-
Stromelysin-3 gene expression in breast and other human carcinomasBellocq, J.-P. / Chenard-Neu, M.-P. / Rouyer, N. / Wolf, C. et al. | 1994
- 99
-
The role of cell adhesion molecules in metastasis formation by solid tumorsJohnson, J. P. et al. | 1994
- 107
-
The invasion suppressor function of E-cadherin in mammary epithelioid cellsBracke, M. E. / Vermeulen, S. J. / Bruyneel, E. A. / Vennekens, K. M. et al. | 1994
- 117
-
Variants of CD44 in human breast cancerHeider, K.-H. / Sinn, H.-P. / Von Minckwitz, G. / Kaufmann, M. et al. | 1994
- 123
-
Induction by urokinase-type plasminogen activator of c-fos gene expression in human ovarian cancer cellsDumler, I. / Petri, T. / Schleuning, W.-D. et al. | 1994
- 133
-
Synthetic peptides for the inhibition of cell-cell and cell-matrix adhesionHaubner, R. / Gurrath, M. / Mueller, G. / Aumailley, M. et al. | 1994
- 145
-
The urokinase/urokinase receptor system - a new target for cancer therapy?Wilhelm, O. / Schmitt, M. / Senekowitsch, R. / Hoehl, S. et al. | 1994
- 157
-
Reduction of metastatic tumor cells in bone marrow of breast cancer patients treated with monoclonal antibodySchlimok, G. / Pantel, K. / Riethmueller, G. et al. | 1994
- 161
-
Intracellular and transmembranic tumor characteristics as targets for diagnosis and therapy: application of 16-[^1^2^3]iodo-17-estradiol and Mab 425 (EGF-R antibody)Beckmann, M. W. / Scharl, A. / Schnuerch, H. G. / Scheidhauer, K. et al. | 1994
- 177
-
Integration of prognostic factors: can we predict breast cancer recurrences?Clark, G. M. / Hilsenbeck, S. G. et al. | 1994
- 187
-
Enzyme-linked immunosorbent assay for plasminogen activator inhibitor-1 (PAI-1)Kramer, M. D. / Link, J. / Reinartz, J. / Buessecker, F. et al. | 1994
- 197
-
Association of PAI-1 with metastasis-free survival in breast cancer: comparison with ER, PgR, PS2, cathepsin D and uPAFoekens, J. A. / Schmitt, M. / Peters, H. A. / Look, M. P. et al. | 1994
- 207
-
Urokinase (uPA) and PAI-1 as selection criteria for adjuvant chemotherapy in axillary node-negative breast cancer patientsJaenicke, F. / Thomssen, C. / Pache, L. / Schmitt, M. et al. | 1994
- 219
-
Importance of menopausal status in breast cancerThorpe, S. M. et al. | 1994
- 223
-
Angiogenin is a valuable prognostic factor in node-negative breast cancerBlaeser, J. / Thomssen, C. / Schmitt, M. / Pache, L. et al. | 1994